Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Dare Bioscience, Inc.

TRADE

NASDAQ: DAREHealthcare / Biotechnology / -
0.95-0.03-3.06%Vol 99 4201Y Perf -69.26%
Oct 19th, 2018 15:57
BID0.95 ASK0.98
Open1.00 Previous Close0.98
Pre-Market- After-Trading-
 - -%  - -%
Target Price
5.94 
Analyst Rating
Strong Buy 1.00
Potencial %
525.26 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/100/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/100/100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/100/100 
Income Ranking
 —    -
Market Cap (mil)11 
Earnings Rating
Neutral
Price Range Ratio 52wk %
7.37 
Earnings Date
12th Nov 2018

Today's Price Range

0.951.01

 

52wk Range

0.743.59

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Month
-5.94%
3 Months
-23.39%
6 Months
13.10%
1 Year
-69.26%
3 Years
-
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
DARE0.95-0.0300-3.06
AAPL219.313.29001.52
GOOG1 096.468.49000.78
MSFT108.660.16000.15
XOM81.970.12000.15
WFC52.89-0.2100-0.40
JNJ139.05-0.4500-0.32
FB154.05-0.8700-0.56
GE12.560.18001.45
JPM107.91-0.1800-0.17
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 9.90
Current Ratio 10.10
Long Term Debt to Total Capital -
Total Debt to Equity 0.00
Interest Coverage -69.10
Leverage Ratio 1.10
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-644.10
EBITDA Margin-644.10
Pre-tax Profit Margin-
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 0.89
PS Ratios 22.95
Price to Cash Flow -
Price to Free Cash Flow -1.80
Cash Flow Per Share -0.92
Price to Tangible Book0.89
Book Value per Share1.07
Enterprise Value (in ths.)-1 538
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)984.94
ROE last 12 Months -268.91
Return on Assets (5Y Avg) -246.68
ROA last 12 Months -201.74
Return on Capital (5Y Avg) -
ROC last 12 Months -270.43
Return on invested Capital Q -25.55
Return on invested Capital Y-177.72
Assets Turnover0.00
Receivables Turnover0.00
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)0
Revenue per Share 0.00
Revenue Growth 3 Years -
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q01 2018--0.28-
Q04 2017--0.49-
Q02 2017--1.42-
Q01 2017-3.10-2.2029.03
Q03 2016-4.30-3.6016.28
Q02 2016-4.80-4.0016.67
Q01 2016-4.20-4.90-16.67
Q04 2015-0.38-0.39-2.63
Earnings Per EndEstimateRevision %Trend
9/2018 QR-0.238.00Positive
12/2018 QR-0.244.00Positive
12/2018 FY-1.03-7.29Negative
12/2019 FY-0.781.27Positive
Next Report Date12th Nov 2018
Estimated EPS Next Report-0.23
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume99 420
Shares Outstanding (in ths.)11 420
Trades Count135
Dollar Volume92 542
Avg. Volume601 675
Avg. Weekly Volume431 463
Avg. Monthly Volume145 266
Avg. Quarterly Volume176 800

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

100%0%

Bearish Bullish

40%60%

Bearish Bullish

77%23%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (100.00 %)
3 (100.00 %)
1 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News

x